Delivery Order SPE2DB22D3501-SPE2DB25FUE08
Award Date
1/15/25
Potential Completion Date
2/6/25
Potential Value
$50K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of REVLIMID 10 MG CAPSULE 28S, a prescription medication, with a ceiling value of $74,890.20. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of April 8, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of REVLIMID 25 MG CAPSULE 21S. The contract has a firm fixed price ceiling value of $37,445.14 and an ultimate completion date of December 12, 2024. This award is a delivery order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by Amerisourcebergen with the DLA Troop Support Medical, which serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $52,448.87 firm fixed-price delivery order contract is for the supply of REVLIMID 5 MG CAPSULE 100S, a medication used in the treatment of various medical conditions. The contract has an ultimate completion date of January 17, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $74,890.20, is a Firm Fixed Price Delivery Order for the supply of REVLIMID 10 MG CAPSULE 28S, a pharmaceutical product. The contract has an ultimate completion date of January 24, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of REVLIMID 10 MG CAPSULE 28S, a pharmaceutical product. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $24,963.40 and a period of performance through April 23, 2025. The contract was awarded on April 2, 2025 and does not have a set-aside designation, indicating...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $49,926.80, is for the delivery of REVLIMID 5 MG CAPSULE 28S, a pharmaceutical product. The contract has an ultimate completion date of March 20, 2025 and is a Firm Fixed Price Delivery Order. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $37,445.14, is a delivery order for the supply of REVLIMID 20 MG CAPSULE 21S. It is a Firm Fixed Price contract with an ultimate completion date of April 2, 2025. The contract is not associated with a set-aside program. Amerisourcebergen Drug Corp is the prime contractor, and there is no mention of...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order valued at $96,586.78 for the provision of REVLIMID 15 MG CAPSULE 100S. The contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a civilian agency that supports the Department of Defense (DoD). Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for delivering a...
This federal contract award is for the delivery of REVLIMID 15 mg capsules to the Defense Logistics Agency (DLA). The $89,155.06 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $89,155.06 and runs through November 25, 2024. There is no set-aside designation, indicating this was an open competition. Amerisourcebergen also holds a $999,999,999 Indefinite Delivery...
This federal contract award is for the delivery of REVLIMID 10 MG CAPSULE 28S to the Defense Logistics Agency (DLA), a defense agency. The $77,905.33 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on August 31, 2022. The contract has an ultimate completion date of September 22, 2022 and was not set aside for any specific business type. AmerisourceBergen holds a $999,999,999 Indefinite Delivery...